Dr. Joshua Garrett Cohen, MD

Dr. Cohen practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Cohen's NPI, 1467605766, was assigned on October 30, 2008. Dr. Cohen graduated from Feinberg School of Medicine in 2007. Dr. Cohen holds California license A105857.

Dr. Cohen's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Cohen's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Dr. Cohen is also affiliated with Providence Mission Hospital. The medical group on file is City of Hope. Dmand AI also links Dr. Cohen to 1 more hospital, 1 group practice or clinic, 1 other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cohen practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Cohen's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Cohen is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dr. Cohen is licensed in California.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Cohen treats.

CMS data shows 712 Medicare services from Dr. Cohen across 9 procedure codes in 2024, for 302 Medicare patients. Medicare paid $74,489 for them.

CMS counts 302 Medicare patients who saw Dr. Cohen in 2024. The largest group is 65 to 74, with 170 patients. 71% of them have high cholesterol, and 65% have high blood pressure. 21% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cohen's median patient age at 64, with 98% women.

In 2024, Dr. Cohen wrote 729 Medicare Part D claims for 167 patients. 88% of them were for generic drugs. CMS names the drug for 521 of them, across 15 drugs with 11 or more claims each, at $460,799 in total drug cost. In 2023, CMS named 278 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Cohen for performance year 2024, reported as part of a group. Dr. Cohen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cohen as offering telehealth. CMS counts 40 procedures of removal of the uterus by Dr. Cohen, more than 98% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 52 papers to Dr. Cohen, published from 2015 to 2025. 2016 was the busiest year, with 6. The most frequent topics are Ovarian Neoplasms, Endometrial Neoplasms and Antineoplastic Combined Chemotherapy Protocols. Dr. Cohen has published most often in Gynecol Oncol. Dr. Cohen's most frequent co-authors are Joshua Cohen, MD, Daniel Stuart Kapp, MD and Margaret I. Liang.

Dmand AI links Dr. Cohen to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Fallopian Tube Diseases, Ovarian Neoplasms and Uterine Cervical Neoplasms. Open Payments lists research payments to Dr. Cohen that name 2 trials.

CMS Open Payments shows 90 general payments to Dr. Cohen from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. AstraZeneca Pharmaceuticals LP paid the most, $5,212. It also lists 4 research payments totaling $782 from 2016 to 2018, naming 2 clinical trials.

Dr. Cohen graduated from Feinberg School of Medicine in 2007. Dr. Cohen is a member of American College of Obstetricians and Gynecologists, ACS and ASCO.

Dr. Cohen is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.